KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables (2016 - 2025)

Historic Receivables for Exact Sciences (EXAS) over the last 12 years, with Q4 2025 value amounting to $298.7 million.

  • Exact Sciences' Receivables rose 865.32% to $298.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $298.7 million, marking a year-over-year increase of 865.32%. This contributed to the annual value of $298.7 million for FY2025, which is 865.32% up from last year.
  • Per Exact Sciences' latest filing, its Receivables stood at $298.7 million for Q4 2025, which was up 865.32% from $337.9 million recorded in Q3 2025.
  • Exact Sciences' Receivables' 5-year high stood at $386.0 million during Q2 2025, with a 5-year trough of $158.0 million in Q4 2022.
  • Its 5-year average for Receivables is $253.7 million, with a median of $252.9 million in 2021.
  • Per our database at Business Quant, Exact Sciences' Receivables skyrocketed by 8289.35% in 2021 and then tumbled by 2704.98% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Receivables stood at $216.6 million in 2021, then decreased by 27.05% to $158.0 million in 2022, then skyrocketed by 55.23% to $245.3 million in 2023, then increased by 12.04% to $274.9 million in 2024, then increased by 8.65% to $298.7 million in 2025.
  • Its Receivables stands at $298.7 million for Q4 2025, versus $337.9 million for Q3 2025 and $386.0 million for Q2 2025.